Cargando…
F1. GENOME-WIDE ASSOCIATION STUDIES SUGGESTED ASSOCIATION BETWEEN DGKB AND ANTIPSYCHOTIC INDUCED WEIGHT GAIN IN EUROPEANS AND AFRICAN AMERICANS
BACKGROUND: Schizophrenia (SCZ) is a severe, devastating disorder with a life-time prevalence of 1% irrespective of gender or ethnic group, treated primarily with antipsychotic (AP) medications. Despite clinical efficacy of APs, they are associated with severe side effects including antipsychotic-in...
Autores principales: | Maciukiewicz, Malgorzata, Tiwari, Arun, Goncalves, Vanessa, Zai, Clement, Brandl, Eva, Freeman, Natalie, Lieberman, Jeffrey, Meltzer, Herbert, Laughlin, Christopher, Nurmi, Erika, Kennedy, James, Mueller, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5888425/ http://dx.doi.org/10.1093/schbul/sby017.532 |
Ejemplares similares
-
M172. POLYGENIC RISK SCORES ANALYSES IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
por: Yoshida, Kazunari, et al.
Publicado: (2020) -
PM389. Preliminary Genetic Model Predicting Clozapine Response
por: Huang, Eric, et al.
Publicado: (2016) -
Role of 5-HT(2C) receptor gene variants in antipsychotic-induced weight gain
por: Wallace, Tessa JM, et al.
Publicado: (2011) -
T7. PHARMACOGENETIC OF TARDIVE DYSKINESIA -- A FOLLOW-UP ON THE VALBENAZINE TARGET VMAT2/SLC18A2
por: Zai, Clement, et al.
Publicado: (2018) -
DGKB mediates radioresistance by regulating DGAT1-dependent lipotoxicity in glioblastoma
por: Kang, Hyunkoo, et al.
Publicado: (2023)